Interpace Biosciences, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2022 | 189.8% | -39.8% | -91.6% |
| Jun 2022 | 195.8% | -97.9% | -201.4% |
| Sep 2022 | 373.5% | -61.6% | -1,121.4% |
| Dec 2022 | 501,100.0% | 5,400.0% | -156,400.0% |
| Mar 2023 | 63.6% | 8.7% | 5.3% |
| Jun 2023 | 65.4% | 11.0% | 5.1% |
| Sep 2023 | 58.5% | 4.5% | -2.0% |
| Dec 2023 | 62.3% | 14.7% | 10.5% |
| Mar 2024 | 62.0% | 10.9% | 7.0% |
| Jun 2024 | 64.8% | 21.9% | 20.2% |
| Sep 2024 | 64.3% | 18.7% | 13.6% |
| Dec 2024 | 63.7% | 16.6% | 15.2% |
| Mar 2025 | 64.0% | 15.9% | 14.3% |
| Jun 2025 | 57.1% | -5.1% | -6.9% |
| Sep 2025 | 62.1% | 13.1% | 10.4% |
| Dec 2025 | 65.5% | 17.1% | 245.6% |
| Mar 2026 | 65.4% | 12.4% | 8.0% |
| Jun 2026 | 61.9% | 3.5% | 1.7% |